Guangshengtang: Covid oral drug GST-HG171 was approved for clinical trials


2022-09-26: [Chinese Article Link] Final update: 2022-09-25 21:55:24 According to the WeChat No. “Hongsong Hall Services”, on 25 September, the Anti-Covid-19 oral drug project, developed by the controlled subsidiary of the listed company Hirosheng Hall, was officially entered into the clinical trial phase with the approval of the National


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.

Trending in China
What China Reads


Guangshengtang: Covid oral drug GST-HG171 was approved for clinical trials


2022-09-26: [Article Link] Final update: 2022-09-25 21:55:24 According to the WeChat No. “Hongsong Hall Services”, on 25 September, the Anti-Covid-19 oral drug project, developed by the controlled subsidiary of the listed company Hirosheng Hall, was officially entered into the clinical trial phase with the approval of the National

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.